MET gene amplification

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (tumor, humanized) 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • AbbVie Deutschland GmbH & Co. KG Commercial
    TELISOTUZUMAB ADIZUTECAN
    2024-518871-74-00 3 countries n=29
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
AbbVie Deutschland GmbH & Co. KG Commercial 1 Phase II 0
← All indication landscapes